Physician

Daniel Rivlin, MD

According to 2025 Medicare claims, Daniel Rivlin, MD (NPI: 1073518692) practices micrographic dermatologic surgery in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is SKIN AND CANCER ASSOCIATES (NPI: 1427017292; TIN: 65-0008133) and primary practice location at 33140-2840.

Rivlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,104 traditional Medicare patients, billed 16,722 HCPCS/CPT codes, and received $1,344,447 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 947 prescription claims across 554 beneficiaries totaling $211,891 in drug costs, led by Humira (Adalimumab). Open Payments data shows 14 records totaling $349. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $95,311 to $211,891. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	5,668	17,625	$1,257,088
2016	5,517	18,631	$1,482,024
2017	5,604	19,323	$1,472,309
2018	4,719	17,436	$1,442,850
2019	5,840	19,184	$1,509,651
2020	5,632	16,634	$1,334,224
2021	5,525	15,512	$1,401,141
2022	4,450	12,355	$1,108,153
2023	6,004	17,005	$1,467,213
2024	6,104	16,722	$1,344,447

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	345	751	$95,311
2016	344	706	$86,378
2017	385	837	$186,165
2018	436	927	$100,879
2019	433	872	$106,351
2020	437	872	$150,024
2021	516	956	$147,445
2022	461	837	$277,609
2023	507	923	$196,307
2024	554	947	$211,891

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	304	381	$453
88312	Special stained specimen slides to identify organisms including interpretation and report	338	446	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	370	624	$65
88305	Pathology examination of tissue using a microscope, intermediate complexity	5,571	11,227	$53
88304	Pathology examination of tissue using a microscope, moderately low complexity	379	456	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira	Adalimumab	12	336	$81,738
Otezla	Apremilast	14	420	$67,170
Doxycycline Hyclate	Doxycycline Hyclate	450	3,554	$3,174
Clobetasol Propionate	Clobetasol Propionate	33	743	$1,470
Mupirocin	Mupirocin	116	2,408	$882

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$349	Ortho Dermatologics, a division of Bausch Health US, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Rivlin, MD?

Tedicare shows public-source Medicare data for Daniel Rivlin, MD (NPI 1073518692), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Rivlin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Rivlin, MD?

Daniel Rivlin, MD is linked to SKIN AND CANCER ASSOCIATES (billing NPI 1427017292) in the available physician profile data.

Does Daniel Rivlin, MD have Open Payments data?

Daniel Rivlin, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.